-- Days : -- HRS : -- MIN : -- SEC

Register for Free →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Miriam Maney, MA, CHPQ

Articles by Miriam Maney, MA, CHPQ

Facility Variation in Utilization of Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes Mellitus and Chronic Kidney Disease

ByAnjali Tiwari, MBBS, MS,Chin-Lin Tseng, DrPH,Elizabeth F. O. Kern, MD,Miriam Maney, MA, CHPQ,Donald R. Miller, ScD,Leonard Pogach, MD, MBA

February 1st 2007

Latest Updated Articles

Facility Variation in Utilization of Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes Mellitus and Chronic Kidney Disease
February 1st 2007

Trending on AJMC

Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%

Real-World AMKD Data Highlight Quick Progression, Unmet Needs

Pulmonary Embolism Can Affect Elite Athletes, Too: Samantha Pettigrew, MD

Experts Weigh Flu Vaccine Timing in Pregnancy and Pediatric Uptake

Durvalumab Plus FLOT Receives Upgrade in New NCCN Guidelines